Literature DB >> 3958919

Transport of cisplatin in rat brain following microinfusion: an analysis.

P F Morrison, R L Dedrick.   

Abstract

The post-microinfusion transport of cis-diamminedichloroplatinum(II) (cisplatin) in rat brain has been modeled as a linear diffusion-reaction-permeation process. The model has been used to analyze the experimental data of Kroin and Penn to obtain the macromolecular binding constant of cisplatin in the brain, k = 0.0050 +/- 0.0023 min-1, and the capillary permeability, p = (9.0 +/- 4.4) X 10(-7) cm/s. Inclusion of saturation effects led to the same p value and a higher k value of 0.007 min-1. The corresponding diffusion length is 0.8 mm. The reaction constant is similar to those reported for plasma (0.008 min-1) and muscle (0.004 min-1), and the permeability value is within the range predicted by correlation with the permeability-octanol/water partition coefficient. Fits to data were accomplished with mathematical expressions giving the average total platinum concentration in saggital cerebellar sections which were not subdivided. Both time-dependent and steady-state solutions were obtained for the transport model, the former predicting a half-time to steady state of 3 h. Boundary effects were also investigated. Concentration profiles, calculated for a point source and for a 23-gauge cannula, were shown to differ by 7%. Similar comparisons between two profiles, one computed for an infinite diffusion range and another computed for drug diffusion into a flowing cerebrospinal fluid (CSF) at a finite range of 3 mm, showed differences of less than 3%. Free and bound drug forms, protein turnover, and CSF uptake have been accounted for as well as the percent infusate recoveries at 100 and 160 h reported by Kroin and Penn.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958919     DOI: 10.1002/jps.2600750204

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  14 in total

Review 1.  Distribution of drugs following controlled delivery to the brain interstitium.

Authors:  M Mak; L Fung; J F Strasser; W M Saltzman
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

2.  Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment.

Authors:  G Los; P H Mutsaers; W J Lenglet; G S Baldew; J G McVie
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

4.  A mathematical model of the impact of infused targeted cytotoxic agents on brain tumours: implications for detection, design and delivery.

Authors:  Lawrence M Wein; Joseph T Wu; Alexandra G Ianculescu; Raj K Puri
Journal:  Cell Prolif       Date:  2002-12       Impact factor: 6.831

5.  Real-time MR imaging with Gadoteridol predicts distribution of transgenes after convection-enhanced delivery of AAV2 vectors.

Authors:  Xiaomin Su; Adrian P Kells; Ernesto A Salegio; Ernesto Aguilar Salegio; R Mark Richardson; Piotr Hadaczek; Janine Beyer; John Bringas; Philip Pivirotto; John Forsayeth; Krystof S Bankiewicz
Journal:  Mol Ther       Date:  2010-06-15       Impact factor: 11.454

6.  Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species.

Authors:  F G King; R L Dedrick; F F Farris
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

Review 7.  Image-guided convection-enhanced delivery platform in the treatment of neurological diseases.

Authors:  Massimo S Fiandaca; John R Forsayeth; Peter J Dickinson; Krystof S Bankiewicz
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 8.  Pharmacokinetics of the carmustine implant.

Authors:  Alison B Fleming; W Mark Saltzman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  Intratumoural administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoural distribution.

Authors:  M J Deurloo; W Kop; O van Tellingen; H Bartelink; A C Begg
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

10.  Diffuse intrinsic pontine glioma: poised for progress.

Authors:  Katherine E Warren
Journal:  Front Oncol       Date:  2012-12-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.